MXCT
MaxCyte, Inc. · Healthcare
EVP, Global Sales, Marketing Thomas M. Ross sold $169K of MaxCyte, Inc.
Sold$169,303
$5.81Price
29,133Shares
−100%Stake
What MXCT did after the filing
- The stock from Tue, Dec 6 close, $5.40
- −1.3%
- S&P 500, same days
- +1.0%
Measured over 30 trading days, to the Jan 20 close.
Traded Fri, Dec 2. Filed Tue, Dec 6, 12:31 PM ET, during the session. Returns use the Dec 6 close and the Jan 20 close. Not investment advice.